u 74389f has been researched along with Conus Medullaris Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, XZ; Haghighi, SS; Hall, ED; Johnson, GC; Oro, JJ | 1 |
| Geng, XZ; Haghighi, SS; Oro, JJ; Padratzik, J; Pérez-Espejo, A; Spollen, L | 1 |
| Harat, M; Kochanowski, J | 1 |
3 other study(ies) available for u 74389f and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Therapeutic value of 21-aminosteroid U74389F in acute spinal cord injury.
Topics: Acute Disease; Animals; Antioxidants; Drug Evaluation, Preclinical; Evoked Potentials, Somatosensory; Hemodynamics; Pregnatrienes; Rats; Rats, Sprague-Dawley; Reaction Time; Spinal Cord Compression; Spinal Cord Injuries | 1993 |
Effect of 21-aminosteroid pretreatment in compression trauma to the spinal cord.
Topics: Animals; Antioxidants; Blood Pressure; Cerebral Cortex; Evoked Potentials, Somatosensory; Female; Heart Rate; Male; Pregnatrienes; Premedication; Rats; Rats, Sprague-Dawley; Spinal Cord Compression; Time Factors | 1994 |
Effect of treatment with 21-aminosteroid U-74389G and glucocorticoid steroid methylprednisolone on somatosensory evoked potentials in rat spinal cord during mild compression.
Topics: Afferent Pathways; Animals; Antioxidants; Disease Models, Animal; Evoked Potentials, Somatosensory; Male; Methylprednisolone; Neuroprotective Agents; Pregnatrienes; Rats; Rats, Wistar; Sciatic Nerve; Somatosensory Cortex; Spinal Cord; Spinal Cord Compression; Spinal Cord Injuries; Statistics, Nonparametric | 1999 |